IGC Pharma
IGC
#10699
Rank
โ‚ฌ23.09 M
Marketcap
0,22ย โ‚ฌ
Share price
1.59%
Change (1 day)
-38.13%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -โ‚ฌ5.61 Million

According to IGC Pharma's latest financial reports the company's current earnings are โ‚ฌ1.18 Million. In 2025 the company made an earning of -โ‚ฌ4.78 Million, an increase over its 2024 earnings that were of -โ‚ฌ7.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.61 Million17.26%
2025 -โ‚ฌ4.78 Million-39.35%
2024 -โ‚ฌ7.88 Million-37.72%
2023 -โ‚ฌ12.65 Million1.19%
2022 -โ‚ฌ12.5 Million21.96%
2021 -โ‚ฌ10.25 Million27.13%
2020 -โ‚ฌ8.07 Million57.16%
2019 -โ‚ฌ5.13 Million85.47%
2018 -โ‚ฌ2.77 Million52.76%
2017 -โ‚ฌ1.82 Million-16.23%
2016 -โ‚ฌ2.17 Million-28.75%
2015 -โ‚ฌ3.04 Million-19.59%
2014 -โ‚ฌ3.78 Million6.79%
2013 -โ‚ฌ3.54 Million-9.47%
2012 -โ‚ฌ3.91 Million-74.03%
2011 -โ‚ฌ15.03 Million119.78%
2010 -โ‚ฌ6.84 Million62.02%
2009 -โ‚ฌ4.22 Million74.39%
2008 -โ‚ฌ2.42 Million-313.12%
2007 โ‚ฌ1.13 M-35.94%
2006 โ‚ฌ1.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
โ‚ฌ0.53 B-9,289.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚ฌ0.67 B-11,587.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-โ‚ฌ59.46 Million 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA